These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 29344328)

  • 1. Management of functional dyspepsia: state of the art and emerging therapies.
    Yamawaki H; Futagami S; Wakabayashi M; Sakasegawa N; Agawa S; Higuchi K; Kodaka Y; Iwakiri K
    Ther Adv Chronic Dis; 2018 Jan; 9(1):23-32. PubMed ID: 29344328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Acotiamide Versus Mosapride in Patients With Functional Dyspepsia Associated With Meal-Induced Postprandial Distress Syndrome: A Phase III Randomized Clinical Trial.
    Sinha S; Chary S; Thakur P; Talluri L; Reddy M; K GS; Mohan JM; Jain P; Naik S; C Reddy SV
    Cureus; 2021 Sep; 13(9):e18109. PubMed ID: 34692320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic options for functional dyspepsia.
    Vanheel H; Tack J
    Dig Dis; 2014; 32(3):230-4. PubMed ID: 24732188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria.
    Vanheel H; Carbone F; Valvekens L; Simren M; Tornblom H; Vanuytsel T; Van Oudenhove L; Tack J
    Am J Gastroenterol; 2017 Jan; 112(1):132-140. PubMed ID: 27958284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.
    Hojo M; Nagahara A; Asaoka D; Takeda T; Izumi K; Matsumoto K; Ueyama H; Shimada Y; Matsumoto K; Nojiri S; Watanabe S
    Digestion; 2017; 96(1):5-12. PubMed ID: 28605740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial distress syndrome: stratification and management.
    Van Den Houte K; Carbone F; Tack J
    Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):37-46. PubMed ID: 30791841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of meal-related symptoms and epigastric pain in patients with functional dyspepsia treated with acotiamide was associated with acylated ghrelin levels in Japan.
    Yamawaki H; Futagami S; Kawagoe T; Maruki Y; Hashimoto S; Nagoya H; Sato H; Kodaka Y; Gudis K; Akamizu T; Sakamoto C; Iwakiri K
    Neurogastroenterol Motil; 2016 Jul; 28(7):1037-47. PubMed ID: 26920949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of acotiamide on postprandial distress syndrome and epigastric pain syndrome depending on the estimated gastric acid secretion level.
    Suzuki T; Ohba R; Kataoka E; Kudo Y; Zeniya A; Segawa D; Oikawa K; Odashima M; Saga T; Kuramitsu T; Sasahara H; Yoneyama K; Tomita T; Shimodaira Y; Iijima K
    J Neurogastroenterol Motil; 2022 Jan; 28(1):53-61. PubMed ID: 34366297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of acotiamide on epigastric pain syndrome and postprandial distress syndrome in patients with functional dyspepsia.
    Shinozaki S; Osawa H; Sakamoto H; Hayashi Y; Kawarai Lefor A; Yamamoto H
    J Med Invest; 2016; 63(3-4):230-5. PubMed ID: 27644564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional dyspepsia--symptoms, definitions and validity of the Rome III criteria.
    Tack J; Talley NJ
    Nat Rev Gastroenterol Hepatol; 2013 Mar; 10(3):134-41. PubMed ID: 23399526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and efficacy of acotiamide in functional dyspepsia (postprandial distress syndrome)-results from the European phase 3 open-label safety trial.
    Tack J; Pokrotnieks J; Urbonas G; Banciu C; Yakusevich V; Bunganic I; Törnblom H; Kleban Y; Eavis P; Tsuchikawa M; Miyagawa T
    Neurogastroenterol Motil; 2018 Jun; 30(6):e13284. PubMed ID: 29315999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride.
    Matsunaga Y; Tanaka T; Yoshinaga K; Ueki S; Hori Y; Eta R; Kawabata Y; Yoshii K; Yoshida K; Matsumura T; Furuta S; Takei M; Tack J; Itoh Z
    J Pharmacol Exp Ther; 2011 Mar; 336(3):791-800. PubMed ID: 21123674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs under development for the treatment of functional dyspepsia and related disorders.
    Tack J; Masuy I; Van Den Houte K; Wauters L; Schol J; Vanuytsel T; Vandenberghe A; Carbone F
    Expert Opin Investig Drugs; 2019 Oct; 28(10):871-889. PubMed ID: 31566013
    [No Abstract]   [Full Text] [Related]  

  • 14. Current and emerging therapeutic options for the management of functional dyspepsia.
    Vandenberghe A; Schol J; Van den Houte K; Masuy I; Carbone F; Tack J
    Expert Opin Pharmacother; 2020 Feb; 21(3):365-376. PubMed ID: 31899982
    [No Abstract]   [Full Text] [Related]  

  • 15. Acotiamide, a novel gastroprokinetic for the treatment of patients with functional dyspepsia: postprandial distress syndrome.
    Altan E; Masaoka T; Farré R; Tack J
    Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):533-44. PubMed ID: 23061703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World, Non-Interventional, Observational Study to Evaluate Effectiveness and Tolerability of Acotiamide Hydrochloride Hydrate in Treatment of Functional Dyspepsia.
    Porika SK; Veligandla KC; Muni SK; Acharya S; Mehta SC; Sharma AD
    Adv Ther; 2018 Nov; 35(11):1884-1893. PubMed ID: 30350248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Orally Administered Acotiamide Extended-Release Tablets Among Functional Dyspepsia-Postprandial Distress Syndrome Patients: A Randomized, Double-Blind, Multicenter Study.
    Sinha SD; Sinha SK; Talluri L; Bhashyakarla RK; Malladi U; Dosi RV; Jain MK; Chary S; Reddy M; Thakur P
    Cureus; 2021 Apr; 13(4):e14361. PubMed ID: 33968542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional dyspepsia.
    Enck P; Azpiroz F; Boeckxstaens G; Elsenbruch S; Feinle-Bisset C; Holtmann G; Lackner JM; Ronkainen J; Schemann M; Stengel A; Tack J; Zipfel S; Talley NJ
    Nat Rev Dis Primers; 2017 Nov; 3():17081. PubMed ID: 29099093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional dyspepsia.
    Brun R; Kuo B
    Therap Adv Gastroenterol; 2010 May; 3(3):145-64. PubMed ID: 21180597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rome III functional dyspepsia subdivision in PDS and EPS: recognizing postprandial symptoms reduces overlap.
    Carbone F; Holvoet L; Tack J
    Neurogastroenterol Motil; 2015 Aug; 27(8):1069-74. PubMed ID: 26220647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.